Compare
SideChannel, Inc. vs Datacentrex, Inc. vs HeartCore Enterprises, Inc. vs BioScience Health Innovations, Inc.
| Latest fiscal year | SideChannel, Inc. SDCH | Datacentrex, Inc. DTCX | HeartCore Enterprises, Inc. HTCR | BioScience Health Innovations, Inc. BHIC |
|---|---|---|---|---|
| Year ended | 2025-09-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $7.35M | $6.96M | $8.97M | $5.69M |
| Revenue growth (YoY) | -0.7% | n/a | -60.5% | +208.3% |
| Gross margin | 47.7% | 48.9% | 35.1% | 57.0% |
| Operating margin | -12.5% | -113.7% | -34.8% | 12.6% |
| Net margin | -12.1% | -122.1% | 64.6% | 11.3% |
| Net income | -$892.0K | -$8.50M | $5.79M | $642.1K |
| EPS (Diluted) | $0.00 | -$0.46 | $0.22 | $0.06 |
| Operating cash flow | -$130.0K | -$6.45M | -$3.12M | $172.2K |
| Free cash flow | n/a | -$32.39M | n/a | n/a |
| Cash & equivalents | n/a | $38.92M | $1.99M | $661.9K |
| Total assets | $3.46M | $66.84M | $13.06M | $1.71M |
| Total liabilities | $1.32M | n/a | $5.78M | $229.9K |
| Shareholders' equity | $2.14M | $66.25M | $8.78M | $1.48M |
| Return on year-end equity | -41.6% | -12.8% | 66.0% | 43.5% |
| Shares outstanding | 231.23M | 30.38M | 25.42M | 10.98M |
Revenue, most recent five fiscal years
| Fiscal year | SideChannel, Inc. | Datacentrex, Inc. | HeartCore Enterprises, Inc. | BioScience Health Innovations, Inc. |
|---|---|---|---|---|
| Latest | $7.35M Ended 2025-09-30 | $6.96M Ended 2025-12-31 | $8.97M Ended 2025-12-31 | $5.69M Ended 2025-12-31 |
| 1 year earlier | $7.40M Ended 2024-09-30 | $741 Ended 2024-12-31 | $22.69M Ended 2024-12-31 | $1.84M Ended 2024-12-31 |
| 2 years earlier | $6.57M Ended 2023-09-30 | $2.0K Ended 2023-12-31 | $21.85M Ended 2023-12-31 | $597.6K Ended 2023-12-31 |
| 3 years earlier | $4.79M Ended 2022-09-30 | $2.4K Ended 2022-12-31 | $8.82M Ended 2022-12-31 | $69.3K Ended 2022-12-31 |
| 4 years earlier | $2.80M Ended 2021-09-30 | $2.4K Ended 2021-12-31 | $10.82M Ended 2021-12-31 | n/a |